| Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More | Frank Vinluan | 07/17/20 | National |
| San Antonio Biomedical Group Awards Miami Healthcare Researcher | David Holley | 08/02/17 | Texas |
| On Front Lines Of Price Dispute, Eye Doctors Wary of New Drug Data | Ben Fidler | 11/01/16 | National |
| For Fledgling San Antonio Companies, Startup Resources Trickling In | David Holley | 09/13/16 | Texas |
| Ex-Blueprint Med CEO Resurfaces With $7.5M to Fight Genetic Blindness | Ben Fidler | 11/09/15 | Boston |
| West Coast Biotech Roundup: Dendreon, Invitae, Juno, Regulus & More | Alex Lash | 02/12/15 | Seattle |
| Two Healthcare Startups Land Venture Funding For Growth | David Holley | 02/10/15 | Boston |
| Acucela Seeks $125M IPO in Japan to Develop Eye Drugs | Luke Timmerman | 12/17/13 | Seattle |
| Freedom Meditech Raises $7M to Market New Diabetes Screening Device | Bruce V. Bigelow | 08/06/13 | San Diego |
| Omeros Seeks FDA Green Light For Eye Surgery Drug | Luke Timmerman | 08/01/13 | Seattle |
| Kala Pharma, From MIT & Johns Hopkins, Grabs $11.5M for Eye Drugs | Luke Timmerman | 02/28/13 | Boston |
| Lux Bio Resurfaces With Defined Path for Pill for Rare Eye Disease | Arlene Weintraub | 07/09/12 | New York |
| Sofinnova Ventures Defies the Grim Mood, Raises $440M For Biotech-Only VC Fund | Luke Timmerman | 10/17/11 | San Francisco |
